In a delayed quarterly disclosure filed on August 14, 2026, major investment firm Farallon Capital Management revealed it had established a new position in UnitedHealth Group. The filing, which reports holdings as of March 31, 2026, showed the acquisition of 1.82 million shares valued at approximately $492.94 million. This new stake represents a significant 2.81% of Farallon's reported portfolio.
The investment period, the first quarter of 2026, was notably challenging for UnitedHealth. The company faced mounting regulatory scrutiny, a Department of Justice investigation, and concerns following a cyberattack on its Change Healthcare subsidiary. During this time, the company's stock experienced downward pressure due to these issues and a forecast for its first annual revenue decline in years.